Table 2 Survival time and treatment response according to the agents
Treatment (n) | Median Survival time (day) | Response (%) |
|---|---|---|
PDS alone (11) | 42 | CR = 3 (27%) |
(range 21–1978) | PR = 3 (27%) | |
NR = 5 (45%) | ||
MMF (26) | 865 | CR = 5 (19%) |
(range 39–2191) | PR = 17 (65%) | |
NR = 4 (15%) | ||
Cyclosporin (18) | 441 | CR = 5 (19%) |
(range 11–2176) | PR = 5 (28%) | |
NR = 8 (44%) | ||
Leflunomide (16) | 1035 | CR = 2 (13%) |
(range 126–2163) | PR = 11 (69%) | |
NR = 3 (19%) | ||
Cytarabine (19) | 754 | CR = 5 (26%) |
(range 6–1898) | PR = 4 (21%) | |
NR = 10 (53%) | ||
MMF + Cytarabine (9) | 132 | PR = 5 (56%) |
(range 23–1227) | NR = 4 (44%) | |
MMF + Cyclosporin (2) | – | PR = 1 (50%) |
NR = 1 (50%) | ||
Cyclosporin + Cytrabine (1) | – | NR = 1 (100%) |